Literature DB >> 3663511

Sickle cell disease in North London.

M O Kehinde1, J C Marsh, G W Marsh.   

Abstract

We have examined our experience of sickle cell disease in the London Borough of Haringey over the past 20 years. There are currently (1986) 145 patients on the Haringey Sickle Cell Register and when comparison is made with other centres, admission for painful crises in Hb SS disease is more frequent than in Jamaica, but the acute chest syndrome appears to be less common in the United Kingdom than in Jamaica. Splenomegaly is less frequent in Hb SC patients in this country and there is also a lower incidence of leg ulceration in both Hb SS and Hb SC disease in the United Kingdom than in Jamaica. The incidence of alloimmunization among transfused sickle cell disease individuals in Haringey is 21%, the most frequently encountered antibodies being anti-E and anti-Kell. All pregnant patients with sickle cell disease were managed with regular blood transfusion throughout pregnancy starting at 12 weeks of gestation. There were no fetal or maternal mortalities, although three babies born were 'small for dates' despite uneventful antenatal courses and adequate Hb A levels being achieved in the mother. Examination of the effect of seasonal variation on the incidence of hospital admissions for painful crises reveals no significant clustering of cases in a particular month or season of the year.

Entities:  

Mesh:

Year:  1987        PMID: 3663511     DOI: 10.1111/j.1365-2141.1987.tb01342.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Environmental determinants of severity in sickle cell disease.

Authors:  Sanjay Tewari; Valentine Brousse; Frédéric B Piel; Stephan Menzel; David C Rees
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

2.  Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

Authors:  A Olujohungbe; K I Cinkotai; A Yardumian
Journal:  BMJ       Date:  1998-06-06

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

4.  Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study.

Authors:  Vikki G Nolan; Yuqing Zhang; Timothy Lash; Paola Sebastiani; Martin H Steinberg
Journal:  Br J Haematol       Date:  2008-08-20       Impact factor: 6.998

5.  Environmental influences on daily emergency admissions in sickle-cell disease patients.

Authors:  Armand Mekontso Dessap; Damien Contou; Claire Dandine-Roulland; François Hemery; Anoosha Habibi; Anaïs Charles-Nelson; Frederic Galacteros; Christian Brun-Buisson; Bernard Maitre; Sandrine Katsahian
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro.

Authors:  Isaac Lima da Silva Filho; Georgina Severo Ribeiro; Patrícia Gomes Moura; Monica Longo Vechi; Andréa Cony Cavalcante; Maria José de Andrada-Serpa
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.